Skip to content
No picture yet

Taro-Enalapril 16 mg – DIN 02352265

Taro-Enalapril is Enalapril Sodium 16 mg (tablet), sold in Canada. It is used for severe high blood pressure, heart failure and a weak heart. It is supplied by Sun Pharma Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Enalapril Sodium 16 mg

Brand
Taro-Enalapril
Strength
16 mg
Used for
Severe high blood pressure, heart failure and a weak heart
Form
Tablet
Manufacturer
Sun Pharma Canada Inc
Drug class
ACE inhibitor (blood pressure and heart medicine)
Sold in
Canada
DIN
02352265

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Enalapril Sodium pills and guides

What is Enalapril Sodium used for?

Enalapril Sodium is used for severe high blood pressure, heart failure, a weak heart and swelling from fluid buildup.

Medicine type
ACE inhibitor (blood pressure and heart medicine)
Official uses from the US prescribing label

Hypertension

Enalapril maleate is indicated for the treatment of hypertension.

Enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of enalapril maleate and thiazides are approximately additive.

Heart Failure

Enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. In these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see CLINICAL PHARMACOLOGY, Heart Failure, Mortality Trials for details and limitations of survival trials).

Asymptomatic Left Ventricular Dysfunction

In clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤35 percent), enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure (see CLINICAL PHARMACOLOGY, Heart Failure, Mortality Trials for details and limitations of survival trials).

In using enalapril maleate consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that enalapril maleate does not have a similar risk (see WARNINGS, Neutropenia/Agranulocytosis).

In considering use of enalapril maleate it should be noted that in controlled clinical trials ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. In addition, it should be noted that black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to non-blacks (see WARNINGS, Head and Neck Angioedema).

From the FDA-approved label on DailyMed (published Sep 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02352265.
  • It names Taro-Enalapril, Enalapril Sodium 16 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Taro-Enalapril by Sun Pharma Canada Inc.

In Canada: prescription only.

Ingredients

Active: Enalapril Sodium

Other Enalapril Sodium pills